Clinical & Translational Immunology (Jan 2022)

Organ‐specific immune response in lethal SARS‐CoV‐2 infection by deep spatial phenotyping

  • Akhila Balachander,
  • Bernett Lee,
  • Subhra K Biswas,
  • David C Lye,
  • Raymond TP Lin,
  • Yee‐Sin Leo,
  • Paul Chui,
  • Lisa FP Ng,
  • Laurent Renia

DOI
https://doi.org/10.1002/cti2.1384
Journal volume & issue
Vol. 11, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Objectives Immunopathology of ongoing COVID‐19 global pandemic is not limited solely to pulmonary tissue, but is often associated with multi‐organ complications, mechanisms of which are intensely being investigated. In this regard, the interplay between immune, stromal cells and cytokines in pulmonary and extrapulmonary infected tissues, especially in young adults (median age 46 years, range 30–53 years) without comorbidities, remains poorly characterised. Methods We profiled lung, heart and intestinal autopsy samples from five SARS‐CoV‐2‐infected cases for 18–20 targets to detect immune, cytokine and stromal cell status at subcellular resolution by a novel IHC‐based deep‐phenotyping technique, iSPOT (immunoSpatial histoPhenOmics using TSA‐IHC), to assess spatial and functional patterns of immune response in situ, in lethal COVID‐19 infection. Results SARS‐CoV‐2‐infected autopsy samples exhibit skewed counts of immune populations in all samples with organ‐specific dysfunctions. Lung and ileal tissue reveal altered architecture with marked loss of tissue integrity, while lung and heart tissue show severe hyperinflammation marked by elevated TNF‐α in heart tissue and additionally IL‐6, IFN‐γ and IL‐10 cytokines in lung samples. Conclusion With resurgence of infection in younger populations, single‐cell cytokine localisation in immune and stromal structures provides important mechanistic insights into organ‐specific immunopathology of naïve SARS‐CoV‐2 infection in the absence of other comorbidities.

Keywords